Published in Pediatr Res on September 08, 2014
Treatment of perinatal viral infections to improve neurologic outcomes. Pediatr Res (2016) 0.75
Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J Gen Virol (1968) 26.67
Neonatal adaptive immunity comes of age. Nat Rev Immunol (2004) 5.31
Three classes of cell surface receptors for alphaherpesvirus entry. Virology (2000) 4.41
THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. II. A CELLULAR BASIS FOR THE DEVELOPMENT OF RESISTANCE WITH AGE. J Exp Med (1964) 3.71
Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J Exp Med (1999) 3.45
Antigenic and biologic differences in herpesvirus hominis. Prog Med Virol (1968) 3.31
Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics (2001) 2.91
Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis (1982) 2.70
Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet (1988) 2.54
Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine. J Infect Dis (1973) 2.53
Herpes simplex encephalitis: adolescents and adults. Antiviral Res (2006) 2.41
The immunoglobulin-like cell adhesion molecule nectin and its associated protein afadin. Annu Rev Cell Dev Biol (2008) 2.30
Neonatal herpes simplex infection. Clin Microbiol Rev (2004) 2.06
Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med (1991) 1.97
Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010. J Infect Dis (2013) 1.80
Alternative entry receptors for herpes simplex virus and their roles in disease. Cell Host Microbe (2007) 1.78
Requirement of interaction of nectin-1alpha/HveC with afadin for efficient cell-cell spread of herpes simplex virus type 1. J Virol (2001) 1.46
Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J Virol (2003) 1.45
Mutational analysis of the virion host shutoff gene (UL41) of herpes simplex virus (HSV): characterization of HSV type 1 (HSV-1)/HSV-2 chimeras. J Virol (1997) 1.22
Infection of neurons and encephalitis after intracranial inoculation of herpes simplex virus requires the entry receptor nectin-1. Proc Natl Acad Sci U S A (2009) 1.16
Cross-regulation between herpesviruses and the TNF superfamily members. Nat Rev Immunol (2008) 1.15
The mouse model and understanding immunity to herpes simplex virus. Rev Infect Dis (1992) 1.12
Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J Infect Dis (1987) 1.06
Host range temperature-sensitive mutants of herpes simplex virus type 2. J Virol (1976) 1.05
Herpesvirus entry mediator and nectin-1 mediate herpes simplex virus 1 infection of the murine cornea. J Virol (2011) 0.96
Activation and evasion of innate antiviral immunity by herpes simplex virus. Viruses (2009) 0.94
The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention. Clin Dev Immunol (2013) 0.93
Functional genomics reveals an essential and specific role for Stat1 in protection of the central nervous system following herpes simplex virus corneal infection. J Virol (2011) 0.92
Functional interaction between herpes simplex virus type 2 gD and HVEM transiently dampens local chemokine production after murine mucosal infection. PLoS One (2011) 0.92
Herpesvirus entry mediator is a serotype specific determinant of pathogenesis in ocular herpes. Proc Natl Acad Sci U S A (2012) 0.89
Herpes simplex virus 2 encephalitis in adults. Mayo Clin Proc (2014) 0.85
The requirements for herpes simplex virus type 1 cell-cell spread via nectin-1 parallel those for virus entry. Virus Res (2006) 0.83
Pathogenesis of neonatal herpes simplex 2 disease in a mouse model is dependent on entry receptor expression and route of inoculation. J Virol (2012) 0.83
Comparison of the host immune response to herpes simplex virus 1 (HSV-1) and HSV-2 at two different mucosal sites. J Virol (2012) 0.81